Clinical Trials Directory

Trials / Completed

CompletedNCT06116344

Improving Prostate Lesion Classification and Development of a PI-RADS 3 Classifier

Improving Prostate Lesion Classification and Diagnostic Accuracy Using Machine Learning: A Comprehensive Evaluation and Development of a PI-RADS 3 Classifier

Status
Completed
Phase
Study type
Observational
Enrollment
173 (actual)
Sponsor
Paracelsus Medical University · Academic / Other
Sex
Male
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The investigators propose an AI methodology combining machine learning, histological results and expert image interpretation for the development of a PI-RADS 3 classifier.

Detailed description

Prostate cancer is the most common carcinoma in male patients in Western industrialized countries. Multiparametric prostate MRI (mpMRI) can select patients who may be potential candidates for biopsy. In this study, the investigators present a comprehensive methodology that evaluates a multitude of AI algorithms and assesses their performance on a large and high-quality dataset, aiming to generate an efficient model and develop a PI-RADS 3 classifier. By combining the power of machine learning with the information provided by mpMRI, histopathological results as well as expert image interpretation, the investigators attempt to improve the diagnostic accuracy, which in the future my lead to more informed clinical decisions and reduce unnecessary biopsies.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2020-12-31
Completion
2023-08-24
First posted
2023-11-03
Last updated
2023-11-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06116344. Inclusion in this directory is not an endorsement.